000 01151 a2200313 4500
005 20250513152419.0
264 0 _c19981007
008 199810s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/s002800051084
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aConley, B A
245 0 0 _aNational Cancer Institute Clinical Trials Program in Colorectal Cancer.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_c1998
300 _aS75-9 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntimetabolites, Antineoplastic
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
_xtrends
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aFluorouracil
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aNational Institutes of Health (U.S.)
650 0 4 _aUnited States
700 1 _aKaplan, R S
700 1 _aArbuck, S G
773 0 _tCancer chemotherapy and pharmacology
_gvol. 42 Suppl
_gp. S75-9
856 4 0 _uhttps://doi.org/10.1007/s002800051084
_zAvailable from publisher's website
999 _c9715002
_d9715002